Li-hua Wang-Kessler

Title: The Innovations of Li-hua Wang-Kessler

Introduction

Li-hua Wang-Kessler is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on mycophenolate mofetil formulations. His expertise and dedication to research have led to advancements that benefit patients requiring specific medication regimens.

Latest Patents

Li-hua Wang-Kessler holds a patent for "Mycophenolate mofetil high dose oral suspensions." This patent describes high dose, dry granulations or powder blends and aqueous oral suspensions of mycophenolate mofetil or mycophenolic acid. The formulation includes an active compound (7.5-30%), suspending/viscosity agent, sweetener, flavor, and buffer to a pH of 5-7.5. Additionally, it may contain optional ingredients such as flavor enhancers, wetting agents, antimicrobial agents, and color.

Career Highlights

Li-hua Wang-Kessler is associated with Syntex (U.S.A.) Inc., where he has contributed to various pharmaceutical innovations. His work has been instrumental in developing effective medication solutions that cater to patient needs. His commitment to research and development has positioned him as a key figure in his field.

Collaborations

Li-hua has collaborated with notable colleagues, including Bindu Joshi and Deborah M Lidgate. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Li-hua Wang-Kessler's contributions to pharmaceutical innovations, particularly in mycophenolate formulations, highlight his role as a significant inventor in the industry. His work continues to impact the field positively, benefiting patients and advancing medical science.